Recursion Pharmaceuticals Inc Clas (RXRX)
Net Income Growth
23.79%
Quarterly · Period ending:
RXRX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported23.79%period ending
Latest reported23.79%period ending
RXRX Quarterly Net Income YoY % (-66.72% → 23.79%)
Year-over-year change
High-resolution chart · PNG
RXRX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 23.7887% | |
| 41.9696% | |
| 39.5638% | |
| -69.5877% | |
| -76.2323% | |
| -121.6049% | |
| -92.3803% | |
| -2.8575% | |
| -27.1277% | |
| -39.8702% | |
| -61.7547% | |
| -53.887% | |
| -17.0317% | |
| -16.6991% | |
| 11.4595% | |
| -27.4458% | |
| -51.0564% | |
| -82.2411% | |
| -152.0104% | |
| -98.668% | |
| -129.1137% | |
| -66.7228% |